WIC
ACOR

Water Island Capital’s Acorda Therapeutics ACOR Stock Holding History

Water Island Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-833
Closed -$2.87M – 133
2018
Q2 		$2.87M Sell
833
-292
-26% -$894K 0.16% 75
2018
Q1 		$3.19M Buy
+1,125
New +$3.37M 0.13% 59

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Water Island Capital's ACOR Position: Q3 2018 in Review

Water Island Capital sold out of Acorda Therapeutics (ACOR) in Q3 2018, closing a stake of 833 shares — an estimated $2.87M sold.

Water Island Capital first reported a position in ACOR in Q1 2018 and held it in 2 quarters. The position peaked at $3.19M in Q1 2018. 174 funds tracked by Wall St. Rank hold ACOR as of Q3 2018.

  • Water Island Capital reported no remaining Acorda Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Water Island Capital sold 833 Acorda Therapeutics shares in Q3 2018, an estimated $2.87M.
  • Water Island Capital first reported a position in Acorda Therapeutics in Q1 2018 and held it in 2 quarters.
  • Water Island Capital's Acorda Therapeutics position peaked at $3.19M in Q1 2018.
  • 174 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2018.

Based on Water Island Capital's 13F filing for Q3 2018, filed 13 Nov 2018.